RxDoctor Payments Data

Helen Pensanti, MD

General Practice · Santa Ana, CANPI 1659707586

Payments from drug & device makers

$560in general payments, 2019–2025

Across 27 payments — averaging $20.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$76
  • Merck$56
  • AstraZeneca$53
  • Medtronic$52
  • Lilly USA, LLC$38
  • Johnson & Johnson$36
  • plus $249 from 11 others

What the payments were for

  • Food & beverage$560100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$560 in reported general payments places this provider in the 70th percentile of 12,963 general practice providers in California.

See all general practice providers in California

Medicare billing

Part B allowed, 2024
$43,900
Medicare patients
254
Services billed
446

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide57$61,191
JardianceEmpagliflozin24$25,828
EliquisApixaban18$25,609
OzempicSemaglutide19$21,389
JanuviaSitagliptin Phosphate15$20,183
Albuterol Sulfate HfaAlbuterol Sulfate107$3,964
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$2,951
Fluticasone-SalmeterolFluticasone Propion/Salmeterol14$2,241
Gabapentin84$1,857
Atorvastatin Calcium208$1,579
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen37$1,122
Levothyroxine Sodium105$1,106
Omeprazole65$976
Trazodone Hcl76$911
Lisinopril173$910

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$38$61,19157 claims
Novo NordiskOzempic$15$21,38919 claims
MerckJanuvia$56$20,18315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 12,963 general practice providers in California.

Other general practice in Santa Ana

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →